Vivo Bio Tech Ltd.
| BSE: 511509 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE380K01017 |
| BSE 00:00 | 23 May | 39.15 |
-0.90 (-2.25%) |
OPEN
40.00 |
HIGH
41.00 |
LOW
38.80 |
| NSE 05:30 | 01 Jan | Vivo Bio Tech Ltd |
| OPEN | 40.00 |
| PREVIOUS CLOSE | 40.05 |
| VOLUME | 4993 |
| 52-Week high | 115.10 |
| 52-Week low | 36.45 |
| P/E | 18.29 |
| Mkt Cap.(Rs cr) | 58 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Vivo Bio Tech Ltd. (VIVOBIOTECH) - Company Information
Vivo Bio Tech Ltd
Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD AAALAC & IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining d...> More
| COMPANY INFORMATION | |||||||
| Whole-time Director : | Kalyan Ram Mangipudi | ||||||
| Director : | Alangudi Sankaranarayanan | ||||||
| Chairman & Independent Directo : | K Sunder | ||||||
| Independent Director : | Hariharan Ravindran | ||||||
| Whole Time Director & CFO : | Tejomurthula Viswaswara Kaladhar Kuppambhotla | ||||||
| Independent Director : | Kunda Kalpana | ||||||
| Director : | Karopadi Shivanand Nayak | ||||||
| WTD & Additional Director : | K Sri Kalyan | ||||||
| AUDITOR : | P C N & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Bulk Drugs | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Survey #349/A Pregnapur Vlge, ,Gajel,Telangana-502311 | |||||||
| Ph : | |||||||
| WEBSITE : http://www.vivobio.com | |||||||
| E-mail : investors@vivobio.com | |||||||
Quick Links for Vivo Bio Tech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
